AKASA vs Collectly (2026)
Two products chasing the same revenue from opposite ends. AKASA works the hospital side of the claim: prebill coding and documentation review, and agents that check authorization and claim status on payer portals. Collectly works the patient's financial path across the visit, from eligibility and cost estimates to statements, payment plans and a billing agent. Look at an aging report before choosing. If coding, documentation and payer lag dominate, AKASA reaches that pool. If the uncollected balance is increasingly owed by patients, no amount of claim work touches it.
- Prebill coding and documentation review from Coding Optimizer and CDI Optimizer, with models fine tuned for each health system.
- Agents that check authorization and claim status on payer portals, with published customer results such as 71.3 percent of accounts cleared from work queues at Methodist.
- In house revenue cycle experts working in the loop, and a stated client base of 500 hospitals.
- The patient financial path in one place, from eligibility and estimates to statements, payment plans and financing.
- Billie, a billing agent in more than 250 languages, by chat, text, email and voice.
- Stated controls: HITRUST i1, a PCI DSS Level 1 processor for cards, AWS hosting and business associate agreements.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. AKASA and Collectly are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | AKASA | Collectly |
|---|---|---|
| Primary category | RCM & Prior Auth AI | RCM & Prior Auth AI |
| Headquarters | South San Francisco, California | San Francisco, California |
| Website | akasa.com | collectly.co |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
AKASA
-
Product / capability
AKASA launched an autonomous platform for inpatient medical coding and clinical documentation integrity, building on its AI prebill review products.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
AKASA, formerly Alpha Health, sells generative AI for the provider side of the revenue cycle to hospitals and health systems. Its listed solutions are the Prebill Optimization Suite, which combines Coding Optimizer (missed coding opportunities, quality and compliance risks) and CDI Optimizer (documentation gaps for clinical documentation integrity teams); AI Advisor, a research assistant for revenue cycle staff; Auth Status, which checks pending prior authorization requests on payer portals and records the results; and Claim Status, which does the same for outstanding claims.
Source: AI Health Index, September 2026
Collectly sells AI revenue cycle automation for patient financial work across the visit. Before the visit, pre-visit intake automation handles digital check-in, insurance card capture, coverage checks, demographic validation and consents. An AI eligibility and benefits agent verifies coverage, retrieves benefits from clearinghouses and payer portals, interprets copays, deductibles and carve-outs, and identifies prior authorization requirements, and AI cost estimation produces patient responsibility and good faith estimates.
Source: AI Health Index, September 2026
Questions buyers ask
How are AKASA and Collectly priced and sold?
AKASA sells to hospitals and health systems by solution, each with its own demo request. The platform page describes a dedicated account manager, production reporting, and the option of AKASA's own revenue cycle experts taking over workflows rather than staff using the tools, a service component that will shape the cost.
Collectly sells through demo requests to medical groups, health systems, billing and revenue cycle companies (which white-label it) and record system vendors (which embed it); the demo form asks for provider count. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 25, 2026. No vendor pays for placement.
How do AKASA and Collectly handle patient data?
In AKASA's case, the data is complete clinical and financial documentation for whole health systems. Safety engineering, meaning guardrails, hallucination mitigation and how a safety event is handled, is not described.
Collectly describes encryption, access control, audit logs and card tokenization through its processor. It also says Billie 'has been trained on hundreds of thousands of real-world patient billing questions', without saying whose conversations those were, whether they were de-identified, or whether customers' patient interactions continue to train the agent. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 25, 2026. No vendor pays for placement.
Which settings and specialties do AKASA and Collectly cover?
AKASA sells to hospitals and health systems, states a client base of 500 hospitals across all 50 states, and covers coding and documentation integrity before billing, prior authorization status, claim status and a research assistant for revenue cycle staff.
Collectly sells to solo and group practices, health systems, urgent care, billing and revenue cycle companies and record system vendors, and reports more than 3,000 healthcare facilities. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 25, 2026. No vendor pays for placement.
What evidence is published for AKASA and Collectly?
For AKASA, the 2024 Authorization Advisor launch claimed up to 50 percent less time on prior authorization and models 38 percent more accurate than GPT-4 at selecting documents, with no test set or method. Cleveland Clinic is deploying the coding and documentation tools, with no results published.
A 2021 case study published through the athenahealth marketplace credits Collectly at CleanSlate Centers, an addiction treatment provider with 76 centers in 10 states, with patient collections up by over 250 percent, paper statements down by over 80 percent and a return on investment above 650 percent. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 25, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
Both records were reviewed on this site in September 2026. Most growing organizations need both halves, so the useful question is where the cash is stuck. Neither publishes an independent evaluation of its returns.
Collectly's billing agent escalates to staff with no published rule for when, and AKASA does not publish the threshold at which work goes to its experts. AKASA publishes no price.